[Analysis of clinical efficiency of treatment for 179 geriatric women with stage I or II cervical carcinoma].
OBJECTIVE
Elderly women with cervical carcinoma have the features of poor prognosis and high incidence rate of complications. This study was designed to evaluate the prognostic impact of surgery versus radiotherapy in old women with stage I and stage II cervical carcinoma and seek suitable treatment for such patients.


METHODS
Clinical data of 179 elderly women with stage Ia to stage IIb cervical cancer were analyzed retrospectively. One hundred and thirty-four cases underwent radical hysterectomy also received appropriate adjuvant radiotherapy and/or chemotherapy. Forty-five cases underwent radiation therapy received appropriate adjuvant chemotherapy.


RESULTS
The 5-year survival rates of patients underwent surgery and radiotherapy were 78.32% and 49.08% (P = 0.04), respectively. The incidence rate of complications of patients receiving surgery was 47.01% (63/134). Three patients died of complications after radical hysterectomy. The incidence rate of complications of patients underwent radiotherapy was 75.63% (34/45).


CONCLUSIONS
Geriatric patients with stage I and stage II cervical carcinoma should receive operation if possible and should receive adjuvant treatments according to personal conditions.
Huang
Yong-wen
YW
Department of Gynecology, Cancer Center, Sun Yat-sen University, Guangzhou 510060, P. R. China.
Li
Meng-da
MD
Liu
Fu-yuan
FY
Li
Yan-fang
YF
D000368:Aged; D000369:Aged, 80 and over; D001918:Brachytherapy; D018196:Carcinoma, Adenosquamous / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007044:Hysterectomy / Q000009:adverse effects / Q000379:methods; D008875:Middle Aged; D009367:Neoplasm Staging; D011183:Postoperative Complications; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D015996:Survival Rate; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*